期刊文献+

老年非小细胞肺癌外科治疗216例临床分析 被引量:6

暂未订购
导出
摘要 目的探讨老年非小细胞肺癌(NSCLC)手术治疗的临床疗效。方法回顾分析我院2002年1月至2006年5月手术治疗的216例老年NSCLC患者的临床资料,对手术方法、病理结果、术后生存率、并发症发生率以及围术期死亡率进行统计分析。结果手术方法:肺叶切除169例(78.2%)、全肺切除16例(7.4%)、复合肺叶切除14例(6.5%)、肺叶支气管袖状切除10例(4.6%)、楔形切除7例(3.2%);病理类型:鳞状上皮细胞癌125例(57.9%)、腺癌77例(35.6%)、腺鳞癌8例(3.7%)、肺泡细胞癌4例(1.9%)、大细胞癌2例(0.9%);TNM分期:Ⅰ期117例(54.2%)、Ⅱ期35例(16.2%)、Ⅲ期64例(29.6%);术后1、3、5年的生存率分别为70.8%、46.3%、28.7%,三年的生存率比较有显著性差异(P<0.05);Ⅰ期、Ⅱ期、Ⅲ期患者的5年生存率分别为42.7%,22.9%,6.3%(P<0.05);并发症发生率为22.2%,围术期死亡率为1.9%。结论对老年NSCLC患者行外科手术治疗时,一定要严格选择手术适应证和手术方式,以降低并发症发生率和死亡率。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第2期269-271,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献9

二级参考文献77

  • 1高禹舜,张德超,赫捷,孙克林,张大为,张汝刚.Ⅰ期非小细胞肺癌的诊断与外科治疗[J].中华肿瘤杂志,2005,27(1):52-55. 被引量:16
  • 2Claire B. POLLOCK,Kathleen KELLY.Mechanisms of cancer metastasis to the bone[J].Cell Research,2005,15(1):57-62. 被引量:58
  • 3刘志东,许绍发,韩毅,秦明,李福根,段勇,粱子昆.70岁以上老年人肺癌273例的外科治疗[J].中华老年医学杂志,2005,24(2):103-105. 被引量:33
  • 4Poleri C, Morevo JL, Nieva B, et al. Risk of recurrence in palients with surgically resected stage Ⅰ non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Chest, 2003, 123 : 1858-1867.
  • 5Mountain CF. Revisions in the International System for Slaging Lung Cancer. Chest, 1997, 111:1710-1717.
  • 6Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Faro Physician, 2007, 75:56-63.
  • 7DouiUant JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin remus observation in patients with completely resected stage Ⅰ B-Ⅲ A non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ ANITA ]): a randomised controlled trial. Lancet Oncol, 2006, 7:719-727.
  • 8Gabor S, Renner H, Popper H, et al. Invasion of blood vessel as significant prognostic factor in radically resected T1-3N0M0 nonsmall-cell lung cancer. Eur J Cardiothorac Surg, 2004, 25:439- 442.
  • 9Ichinose Y, Yano T, Asoh H, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer: an analysis in each pathologic stage. J Thorac Cardiovasc Stag, 1995, 110:601-605.
  • 10Angeletti CA, Lucchi M, Fontanini G, et al. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma ( stage ⅢA-N2) :impact of adjuvant therapies in a subset of patients at high risk of recurrence. Cancer, 1996, 78:409-415.

共引文献120

同被引文献54

  • 1郝捷,赵平,陈万青.2011中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:1,206-207.
  • 2Jemal A, Bray F, Center MM, et al. Global Cancer statistics[J].CA Cancer J Clin, 2011, 61(2):69-90.
  • 3Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung eancer: Diagnosis and man- agement of lung cancer, 3rd ed: American College of chest Physicians evidence-based clinical practice guidelines [ J ]. Chest, 2013:143(5) :278-313.
  • 4Robinson CG, Dewees TA, E1 Naqa IM, et al. Patterns of failure after stereotactic body radiation therapy or lobar resec- tion for clinical stage I non-small-cell lung Cancer[J]. J Thorae Oncol, 2013, 8(2):192-201.
  • 5Varlotto J, Fakiris A, Flickinger J, et al. Matched-Pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stefeotactic radiosurgery [J]. Cancer, 2013, 119 (15) : 2683-2691.
  • 6Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung Cancer[J]. J Thorac Cardiovasc Surg, 2010, 140(2) :377-386.
  • 7Palma D, Visser O, Lagerwaard FJ, et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery[J]. Ra- diother Oncol, 2011, 101(2) :240-244.
  • 8Su S, Scott WJ, Allen MS, et al. Patterns of survival and re currence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial [J]. J Thorae Cardiovasc Surg, 2014, 147(2) :747-752.
  • 9Li HQ, Wang YJ, Li J, et al. The application of gamma ster- eotactic body radiation therapy in stage I/II non-small-cell lung eaneer[J]. Saudi Med J, 2013, 34(11) :1139-1144.
  • 10Cuaron JJ, Yorke ED, Foster A, et al. Stereotactic body ra- diation therapy for primary lung cancers >3 centimeters[J]. J Thorae Oneol, 2013, 8(11):1396-1401.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部